Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$102.48
+2.0%		$105.47
$81.97
▼
$132.02
$176.95B0.5911.31 million shs6.72 million shs
lululemon athletica inc. stock logo
LULU
lululemon athletica
$103.30
+7.0%		$104.58
$90.38
▼
$225.98
$11.89B0.923.67 million shs4.10 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-2.04%-2.38%-2.32%-0.28%-21.22%
lululemon athletica inc. stock logo
LULU
lululemon athletica
-3.41%+2.59%-4.71%-12.75%-46.78%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$102.48
+2.0%		$105.47
$81.97
▼
$132.02
$176.95B0.5911.31 million shs6.72 million shs
lululemon athletica inc. stock logo
LULU
lululemon athletica
$103.30
+7.0%		$104.58
$90.38
▼
$225.98
$11.89B0.923.67 million shs4.10 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-2.04%-2.38%-2.32%-0.28%-21.22%
lululemon athletica inc. stock logo
LULU
lululemon athletica
-3.41%+2.59%-4.71%-12.75%-46.78%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.93
Moderate Buy$117.8416.42% Upside
lululemon athletica inc. stock logo
LULU
lululemon athletica
1.80
Reduce$105.264.11% Upside

Current Analyst Ratings Breakdown

Latest LULU and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$112.00 ➝ $119.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetOverweight$120.00 ➝ $118.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$135.00 ➝ $118.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$134.00 ➝ $125.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOutperform$121.00 ➝ $123.00
10/22/2026
lululemon athletica inc. stock logo
LULU
lululemon athletica
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageUnderperform$75.00
10/19/2026
lululemon athletica inc. stock logo
LULU
lululemon athletica
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetEqual Weight$95.00 ➝ $90.00
10/16/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$135.00
10/8/2026
lululemon athletica inc. stock logo
LULU
lululemon athletica
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (D) ➝ Sell (D+)
10/7/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageOverweight$120.00
10/2/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeNeutral ➝ Buy$119.00 ➝ $127.00
(Data available from 10/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$46.59B3.76$6.91 per share14.65$30.35 per share3.34
lululemon athletica inc. stock logo
LULU
lululemon athletica
$11.10B1.05$17.25 per share5.86$40.80 per share2.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.0932.7816.651.9011.65%17.69%9.44%N/A
lululemon athletica inc. stock logo
LULU
lululemon athletica
$1.58B$12.218.2711.732.3812.78%27.69%15.81%12/10/2026 (Estimated)

Latest LULU and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/21/2026Q3 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.42$1.42N/A$0.53$12.99 billion$13.01 billion
9/3/2026Q2 2026
lululemon athletica inc. stock logo
LULU
lululemon athletica
$1.79$2.92+$1.13$2.92$2.46 billion$2.42 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.51%+10.39%81.55%54 Years
lululemon athletica inc. stock logo
LULU
lululemon athletica
N/AN/AN/AN/AN/A

Latest LULU and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.4%10/15/202610/15/202611/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.57
1.38
0.97
lululemon athletica inc. stock logo
LULU
lululemon athletica
N/A
2.19
1.24

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
lululemon athletica inc. stock logo
LULU
lululemon athletica
85.20%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
lululemon athletica inc. stock logo
LULU
lululemon athletica
0.54%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.72 billionOptionable
lululemon athletica inc. stock logo
LULU
lululemon athletica
39,000115.83 million115.20 millionOptionable

Recent News About These Companies

Lululemon (LULU) Stock Looks Overvalued Following Its 78% Five Year Slump
 |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/lululemon-lulu-stock-looks-overvalued-131614165.html
Lululemon rises as investors appear to favor a rebound in the beaten-down retailer
 |  quiverquant.comQ
Wolfe Research Initiates Coverage on lululemon athletica (NASDAQ:LULU)
October 22 at 7:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-wolfe-research-initiates-coverage-on-lululemon-athletica-nasdaq-lulu-2026-10-22/
Can lululemon Athletica (NASDAQ:LULU) Rebuild Its Momentum?
October 21 at 6:49 PM  |  kalkinemedia.comK
lululemon's Americas Sales Slump Deepens Turnaround Concerns
October 21 at 1:45 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/lululemons-americas-sales-slump-deepens-140000739.html
Teen spending up 6% as they trade athletic apparel for fashion
October 21 at 1:45 PM  |  retaildive.comR
Lululemon Is Down 54% and Trades at 8.5 Times Earnings. Is Wall Street Getting This Stock Wrong?
October 21 at 1:15 PM  |  fool.comhttps://www.fool.com/investing/2026/10/21/lululemon-down-54-and-trades-at-8-times-earnings/
lululemon's Americas Sales Slump Deepens Turnaround Concerns
October 21 at 12:01 PM  |  zacks.comhttps://www.zacks.com/stock/news/3012029/lululemon-s-americas-sales-slump-deepens-turnaround-concerns?cid=cs-stocknewsapi-ft-analyst_blog|zer_report_update-3012029
LULU Loss Notice: Lululemon Investors are Reminded of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money
October 21 at 6:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/21/3385300/0/en/lulu-loss-notice-lululemon-investors-are-reminded-of-the-pending-securities-fraud-investigation-contact-bfa-law-if-you-lost-money.html
Wells Fargo & Company Has Lowered Expectations for lululemon athletica (NASDAQ:LULU) Stock Price
October 21 at 1:30 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31141126
Wells Fargo cuts target to USD 90.00 for Lululemon Athletica stock
October 20 at 12:10 AM  |  ad-hoc-news.deA
Lululemon Is Reorganizing Its Leadership Team. The Real Test Is What Happens Between the Boxes
October 20 at 2:09 PM  |  inc.comhttps://www.inc.com/scott-hutcheson/lululemon-reorganization-leadership-tests/91422720
Investors Heavily Search lululemon athletica inc. (LULU): Here is What You Need to Know
October 20 at 2:09 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/investors-heavily-search-lululemon-athletica-120004240.html
lululemon: Don't Confuse Crisis With Death
October 20 at 12:00 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4955535-lululemon-dont-confuse-crisis-with-death
LULULEMON ATHLETICA INC. (LULU) Securities Investigation Notice - Levi & Korsinsky
October 20 at 10:15 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/lululemon-athletica-inc-lulu-securities-investigation-notice---levi--korsinsky-302913847.html
Investors Heavily Search lululemon athletica inc. (LULU): Here is What You Need to Know
October 20 at 10:01 AM  |  zacks.comhttps://www.zacks.com/stock/news/3010945/investors-heavily-search-lululemon-athletica-inc-lulu-here-is-what-you-need-to-know?cid=cs-stocknewsapi-ft-fundamental_analysis|most_searched_stocks-3010945
lululemon: The Turnaround Is A Bet, Not A Bargain
October 20 at 6:19 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4955431-lululemon-stock-turnaround-bet-not-bargain
lululemon athletica inc. $LULU Shares Acquired by Assenagon Asset Management S.A.
October 20 at 3:04 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-lululemon-athletica-inc-lulu-shares-acquired-by-assenagon-asset-management-sa-2026-10-20/
Is Lululemon's Next Big Thing Already Here?
October 19 at 1:57 PM  |  trefis.comT
lululemon athletica (NASDAQ:LULU) Stock Price Target Cut by Wells Fargo & Company
October 19 at 10:47 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-lululemon-athletica-nasdaq-lulu-stock-price-target-cut-by-wells-fargo-company-2026-10-19/
Why Is Lululemon Stock Rising, and Is It a Buying Opportunity?
October 19 at 8:40 AM  |  fool.comhttps://www.fool.com/investing/2026/10/19/why-is-lululemon-stock-rising-and-is-it-a-buying-o/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Illuminated Nike swoosh logo on a wall above a display pedestal with sneakers in a retail store.
Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?
By Thomas Hughes | October 4, 2026
Close-up of an Nvidia logo on a computer chip mounted on a circuit board with cables and hardware components.
NVIDIA Just Strengthened the Case for Its Massive Stock Price Upside
By Thomas Hughes | September 29, 2026
Kalshi and Polymarket logos beside a smartphone showing a prediction market on the Chiefs winning the Super Bowl, with a football in the background.
Want Private-Market Access to Kalshi and Polymarket? Try This ETF
By Jessica Mitacek | October 8, 2026
Digital screen displays a red candlestick stock chart trending downward, illustrating a declining market against a city skyline.
3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
By Dan Schmidt | October 11, 2026
Branded box, container, syringe applicator, and sealed packets with a CP logo displayed on a bathroom counter.
Cologuard Is Working—So Why Isn’t Abbott Stock?
By Chris Markoch | October 22, 2026
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$102.62 +2.12 (+2.10%)
As of 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

lululemon athletica stock logo

lululemon athletica NASDAQ:LULU

$104.06 +7.53 (+7.80%)
As of 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Lululemon Athletica Inc., together with its subsidiaries, designs, distributes, and retails athletic apparel, footwear, and accessories under the lululemon brand for women and men. It offers pants, shorts, tops, and jackets for healthy lifestyle, such as yoga, running, training, and other activities. It also provides fitness-inspired accessories. The company sells its products through a chain of company-operated stores; outlets; interactive workout platform; yoga and fitness studios, university campus retailers, and other partners; license and supply arrangements; and temporary locations, as well as through mobile apps and lululemon.com e-commerce website. It has operations in the United States, Canada, Mainland China, Australia, South Korea, Hong Kong, Japan, New Zealand, Taiwan, Singapore, Malaysia, Macau, Thailand, the Asia Pacific, the United Kingdom, Germany, France, Ireland, Spain, the Netherlands, Sweden, Norway, Switzerland, Europe, the Middle East, and Africa. Lululemon Athletica Inc. was founded in 1998 and is based in Vancouver, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas